nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—CYP3A4—Esomeprazole—Barrett's esophagus	0.149	0.389	CbGbCtD
Tacrolimus—ABCB1—Omeprazole—Barrett's esophagus	0.147	0.382	CbGbCtD
Tacrolimus—CYP3A4—Omeprazole—Barrett's esophagus	0.0878	0.229	CbGbCtD
Tacrolimus—ORM1—bile—Barrett's esophagus	0.0306	0.369	CbGeAlD
Tacrolimus—PPP3CA—smooth muscle tissue—Barrett's esophagus	0.00814	0.0981	CbGeAlD
Tacrolimus—PPP3CA—digestive system—Barrett's esophagus	0.00643	0.0774	CbGeAlD
Tacrolimus—MTOR—epithelium—Barrett's esophagus	0.00624	0.0752	CbGeAlD
Tacrolimus—MTOR—smooth muscle tissue—Barrett's esophagus	0.00601	0.0724	CbGeAlD
Tacrolimus—FKBP1A—epithelium—Barrett's esophagus	0.00561	0.0676	CbGeAlD
Tacrolimus—FKBP1A—smooth muscle tissue—Barrett's esophagus	0.00541	0.0651	CbGeAlD
Tacrolimus—MTOR—digestive system—Barrett's esophagus	0.00475	0.0572	CbGeAlD
Tacrolimus—FKBP1A—digestive system—Barrett's esophagus	0.00427	0.0514	CbGeAlD
Tacrolimus—ALB—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00253	0.0502	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—BMP4—Barrett's esophagus	0.00199	0.0396	CbGpPWpGaD
Tacrolimus—CYP3A5—digestive system—Barrett's esophagus	0.00186	0.0224	CbGeAlD
Tacrolimus—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00161	0.0319	CbGpPWpGaD
Tacrolimus—PPP3CA—G Protein Signaling Pathways—SLC9A1—Barrett's esophagus	0.00158	0.0314	CbGpPWpGaD
Tacrolimus—CYP3A4—digestive system—Barrett's esophagus	0.0014	0.0168	CbGeAlD
Tacrolimus—PPP3CA—Initiation of transcription and translation elongation at the HIV-1 LTR—RELA—Barrett's esophagus	0.00137	0.0273	CbGpPWpGaD
Tacrolimus—Arthritis—Omeprazole—Barrett's esophagus	0.00135	0.0028	CcSEcCtD
Tacrolimus—Arthritis—Esomeprazole—Barrett's esophagus	0.00135	0.0028	CcSEcCtD
Tacrolimus—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00135	0.00279	CcSEcCtD
Tacrolimus—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00135	0.00279	CcSEcCtD
Tacrolimus—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00132	0.00273	CcSEcCtD
Tacrolimus—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00132	0.00273	CcSEcCtD
Tacrolimus—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00132	0.00272	CcSEcCtD
Tacrolimus—Pain in extremity—Omeprazole—Barrett's esophagus	0.00132	0.00272	CcSEcCtD
Tacrolimus—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00132	0.00272	CcSEcCtD
Tacrolimus—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00132	0.00272	CcSEcCtD
Tacrolimus—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00132	0.00272	CcSEcCtD
Tacrolimus—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00132	0.00272	CcSEcCtD
Tacrolimus—ABCB1—epithelium—Barrett's esophagus	0.0013	0.0156	CbGeAlD
Tacrolimus—Migraine—Omeprazole—Barrett's esophagus	0.00129	0.00268	CcSEcCtD
Tacrolimus—Migraine—Esomeprazole—Barrett's esophagus	0.00129	0.00268	CcSEcCtD
Tacrolimus—Face oedema—Esomeprazole—Barrett's esophagus	0.00127	0.00263	CcSEcCtD
Tacrolimus—Face oedema—Omeprazole—Barrett's esophagus	0.00127	0.00263	CcSEcCtD
Tacrolimus—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00123	0.00255	CcSEcCtD
Tacrolimus—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00123	0.00255	CcSEcCtD
Tacrolimus—Dry skin—Esomeprazole—Barrett's esophagus	0.00121	0.0025	CcSEcCtD
Tacrolimus—Dry skin—Omeprazole—Barrett's esophagus	0.00121	0.0025	CcSEcCtD
Tacrolimus—Hypokalaemia—Omeprazole—Barrett's esophagus	0.0012	0.00248	CcSEcCtD
Tacrolimus—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.0012	0.00248	CcSEcCtD
Tacrolimus—Breast disorder—Esomeprazole—Barrett's esophagus	0.00119	0.00246	CcSEcCtD
Tacrolimus—Breast disorder—Omeprazole—Barrett's esophagus	0.00119	0.00246	CcSEcCtD
Tacrolimus—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00118	0.00245	CcSEcCtD
Tacrolimus—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00118	0.00245	CcSEcCtD
Tacrolimus—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00118	0.00245	CcSEcCtD
Tacrolimus—Cramp muscle—Omeprazole—Barrett's esophagus	0.00118	0.00245	CcSEcCtD
Tacrolimus—Gastritis—Esomeprazole—Barrett's esophagus	0.00116	0.00241	CcSEcCtD
Tacrolimus—Gastritis—Omeprazole—Barrett's esophagus	0.00116	0.00241	CcSEcCtD
Tacrolimus—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00116	0.0024	CcSEcCtD
Tacrolimus—Muscular weakness—Omeprazole—Barrett's esophagus	0.00116	0.0024	CcSEcCtD
Tacrolimus—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00114	0.00237	CcSEcCtD
Tacrolimus—Abdominal distension—Omeprazole—Barrett's esophagus	0.00114	0.00237	CcSEcCtD
Tacrolimus—Asthma—Omeprazole—Barrett's esophagus	0.00114	0.00235	CcSEcCtD
Tacrolimus—Asthma—Esomeprazole—Barrett's esophagus	0.00114	0.00235	CcSEcCtD
Tacrolimus—Influenza—Esomeprazole—Barrett's esophagus	0.00114	0.00235	CcSEcCtD
Tacrolimus—Influenza—Omeprazole—Barrett's esophagus	0.00114	0.00235	CcSEcCtD
Tacrolimus—Dysphagia—Omeprazole—Barrett's esophagus	0.00114	0.00235	CcSEcCtD
Tacrolimus—Dysphagia—Esomeprazole—Barrett's esophagus	0.00114	0.00235	CcSEcCtD
Tacrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—Barrett's esophagus	0.00112	0.0222	CbGpPWpGaD
Tacrolimus—Pancreatitis—Omeprazole—Barrett's esophagus	0.00111	0.00231	CcSEcCtD
Tacrolimus—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00111	0.00231	CcSEcCtD
Tacrolimus—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00111	0.00229	CcSEcCtD
Tacrolimus—Sweating increased—Esomeprazole—Barrett's esophagus	0.00111	0.00229	CcSEcCtD
Tacrolimus—Sweating increased—Omeprazole—Barrett's esophagus	0.00111	0.00229	CcSEcCtD
Tacrolimus—Angina pectoris—Omeprazole—Barrett's esophagus	0.00111	0.00229	CcSEcCtD
Tacrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.00109	0.0216	CbGpPWpGaD
Tacrolimus—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00108	0.00223	CcSEcCtD
Tacrolimus—Pancytopenia—Omeprazole—Barrett's esophagus	0.00108	0.00223	CcSEcCtD
Tacrolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00107	0.0213	CbGpPWpGaD
Tacrolimus—Neutropenia—Omeprazole—Barrett's esophagus	0.00106	0.0022	CcSEcCtD
Tacrolimus—Dysuria—Omeprazole—Barrett's esophagus	0.00106	0.0022	CcSEcCtD
Tacrolimus—Neutropenia—Esomeprazole—Barrett's esophagus	0.00106	0.0022	CcSEcCtD
Tacrolimus—Dysuria—Esomeprazole—Barrett's esophagus	0.00106	0.0022	CcSEcCtD
Tacrolimus—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00106	0.021	CbGpPWpGaD
Tacrolimus—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00105	0.00217	CcSEcCtD
Tacrolimus—Pollakiuria—Omeprazole—Barrett's esophagus	0.00105	0.00217	CcSEcCtD
Tacrolimus—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00104	0.00215	CcSEcCtD
Tacrolimus—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00104	0.00215	CcSEcCtD
Tacrolimus—Weight increased—Esomeprazole—Barrett's esophagus	0.00103	0.00214	CcSEcCtD
Tacrolimus—Weight increased—Omeprazole—Barrett's esophagus	0.00103	0.00214	CcSEcCtD
Tacrolimus—Weight decreased—Omeprazole—Barrett's esophagus	0.00103	0.00213	CcSEcCtD
Tacrolimus—Weight decreased—Esomeprazole—Barrett's esophagus	0.00103	0.00213	CcSEcCtD
Tacrolimus—Infestation—Omeprazole—Barrett's esophagus	0.00101	0.0021	CcSEcCtD
Tacrolimus—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00101	0.0021	CcSEcCtD
Tacrolimus—Infestation NOS—Omeprazole—Barrett's esophagus	0.00101	0.0021	CcSEcCtD
Tacrolimus—Infestation—Esomeprazole—Barrett's esophagus	0.00101	0.0021	CcSEcCtD
Tacrolimus—Depression—Omeprazole—Barrett's esophagus	0.00101	0.00209	CcSEcCtD
Tacrolimus—Depression—Esomeprazole—Barrett's esophagus	0.00101	0.00209	CcSEcCtD
Tacrolimus—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.001	0.00208	CcSEcCtD
Tacrolimus—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.001	0.00208	CcSEcCtD
Tacrolimus—Renal failure—Esomeprazole—Barrett's esophagus	0.000996	0.00206	CcSEcCtD
Tacrolimus—Renal failure—Omeprazole—Barrett's esophagus	0.000996	0.00206	CcSEcCtD
Tacrolimus—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000989	0.0196	CbGpPWpGaD
Tacrolimus—Stomatitis—Esomeprazole—Barrett's esophagus	0.000988	0.00205	CcSEcCtD
Tacrolimus—Jaundice—Omeprazole—Barrett's esophagus	0.000988	0.00205	CcSEcCtD
Tacrolimus—Stomatitis—Omeprazole—Barrett's esophagus	0.000988	0.00205	CcSEcCtD
Tacrolimus—Jaundice—Esomeprazole—Barrett's esophagus	0.000988	0.00205	CcSEcCtD
Tacrolimus—ABCB1—digestive system—Barrett's esophagus	0.000988	0.0119	CbGeAlD
Tacrolimus—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000985	0.00204	CcSEcCtD
Tacrolimus—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000985	0.00204	CcSEcCtD
Tacrolimus—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000985	0.00204	CcSEcCtD
Tacrolimus—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000985	0.00204	CcSEcCtD
Tacrolimus—MTOR—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000974	0.0193	CbGpPWpGaD
Tacrolimus—Haematuria—Omeprazole—Barrett's esophagus	0.000966	0.002	CcSEcCtD
Tacrolimus—Haematuria—Esomeprazole—Barrett's esophagus	0.000966	0.002	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000959	0.00198	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000959	0.00198	CcSEcCtD
Tacrolimus—Epistaxis—Esomeprazole—Barrett's esophagus	0.000956	0.00198	CcSEcCtD
Tacrolimus—Epistaxis—Omeprazole—Barrett's esophagus	0.000956	0.00198	CcSEcCtD
Tacrolimus—Sinusitis—Esomeprazole—Barrett's esophagus	0.000951	0.00197	CcSEcCtD
Tacrolimus—Sinusitis—Omeprazole—Barrett's esophagus	0.000951	0.00197	CcSEcCtD
Tacrolimus—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000946	0.00196	CcSEcCtD
Tacrolimus—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000946	0.00196	CcSEcCtD
Tacrolimus—Bradycardia—Esomeprazole—Barrett's esophagus	0.000926	0.00192	CcSEcCtD
Tacrolimus—Bradycardia—Omeprazole—Barrett's esophagus	0.000926	0.00192	CcSEcCtD
Tacrolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000922	0.0183	CbGpPWpGaD
Tacrolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000922	0.0183	CbGpPWpGaD
Tacrolimus—Rhinitis—Esomeprazole—Barrett's esophagus	0.000912	0.00189	CcSEcCtD
Tacrolimus—Rhinitis—Omeprazole—Barrett's esophagus	0.000912	0.00189	CcSEcCtD
Tacrolimus—Hepatitis—Esomeprazole—Barrett's esophagus	0.00091	0.00188	CcSEcCtD
Tacrolimus—Hepatitis—Omeprazole—Barrett's esophagus	0.00091	0.00188	CcSEcCtD
Tacrolimus—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000905	0.00187	CcSEcCtD
Tacrolimus—Hallucination—Esomeprazole—Barrett's esophagus	0.000905	0.00187	CcSEcCtD
Tacrolimus—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000905	0.00187	CcSEcCtD
Tacrolimus—Hallucination—Omeprazole—Barrett's esophagus	0.000905	0.00187	CcSEcCtD
Tacrolimus—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000903	0.00187	CcSEcCtD
Tacrolimus—Pharyngitis—Omeprazole—Barrett's esophagus	0.000903	0.00187	CcSEcCtD
Tacrolimus—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000899	0.00186	CcSEcCtD
Tacrolimus—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000899	0.00186	CcSEcCtD
Tacrolimus—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000896	0.00186	CcSEcCtD
Tacrolimus—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000896	0.00186	CcSEcCtD
Tacrolimus—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000894	0.00185	CcSEcCtD
Tacrolimus—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000894	0.00185	CcSEcCtD
Tacrolimus—Urethral disorder—Omeprazole—Barrett's esophagus	0.000892	0.00185	CcSEcCtD
Tacrolimus—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000892	0.00185	CcSEcCtD
Tacrolimus—Visual impairment—Esomeprazole—Barrett's esophagus	0.000877	0.00182	CcSEcCtD
Tacrolimus—Visual impairment—Omeprazole—Barrett's esophagus	0.000877	0.00182	CcSEcCtD
Tacrolimus—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00087	0.0173	CbGpPWpGaD
Tacrolimus—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00086	0.00178	CcSEcCtD
Tacrolimus—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00086	0.00178	CcSEcCtD
Tacrolimus—Eye disorder—Esomeprazole—Barrett's esophagus	0.00085	0.00176	CcSEcCtD
Tacrolimus—Eye disorder—Omeprazole—Barrett's esophagus	0.00085	0.00176	CcSEcCtD
Tacrolimus—Tinnitus—Omeprazole—Barrett's esophagus	0.000848	0.00176	CcSEcCtD
Tacrolimus—Tinnitus—Esomeprazole—Barrett's esophagus	0.000848	0.00176	CcSEcCtD
Tacrolimus—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000848	0.0168	CbGpPWpGaD
Tacrolimus—Flushing—Omeprazole—Barrett's esophagus	0.000844	0.00175	CcSEcCtD
Tacrolimus—Flushing—Esomeprazole—Barrett's esophagus	0.000844	0.00175	CcSEcCtD
Tacrolimus—Immune system disorder—Omeprazole—Barrett's esophagus	0.000822	0.0017	CcSEcCtD
Tacrolimus—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000822	0.0017	CcSEcCtD
Tacrolimus—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00082	0.0017	CcSEcCtD
Tacrolimus—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00082	0.0017	CcSEcCtD
Tacrolimus—Chills—Esomeprazole—Barrett's esophagus	0.000816	0.00169	CcSEcCtD
Tacrolimus—Chills—Omeprazole—Barrett's esophagus	0.000816	0.00169	CcSEcCtD
Tacrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.000807	0.016	CbGpPWpGaD
Tacrolimus—Alopecia—Esomeprazole—Barrett's esophagus	0.000804	0.00166	CcSEcCtD
Tacrolimus—Alopecia—Omeprazole—Barrett's esophagus	0.000804	0.00166	CcSEcCtD
Tacrolimus—Mental disorder—Omeprazole—Barrett's esophagus	0.000797	0.00165	CcSEcCtD
Tacrolimus—Mental disorder—Esomeprazole—Barrett's esophagus	0.000797	0.00165	CcSEcCtD
Tacrolimus—Malnutrition—Esomeprazole—Barrett's esophagus	0.000792	0.00164	CcSEcCtD
Tacrolimus—Malnutrition—Omeprazole—Barrett's esophagus	0.000792	0.00164	CcSEcCtD
Tacrolimus—Flatulence—Omeprazole—Barrett's esophagus	0.00078	0.00162	CcSEcCtD
Tacrolimus—Flatulence—Esomeprazole—Barrett's esophagus	0.00078	0.00162	CcSEcCtD
Tacrolimus—Tension—Esomeprazole—Barrett's esophagus	0.000777	0.00161	CcSEcCtD
Tacrolimus—Tension—Omeprazole—Barrett's esophagus	0.000777	0.00161	CcSEcCtD
Tacrolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000776	0.0154	CbGpPWpGaD
Tacrolimus—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000776	0.00161	CcSEcCtD
Tacrolimus—Dysgeusia—Omeprazole—Barrett's esophagus	0.000776	0.00161	CcSEcCtD
Tacrolimus—Nervousness—Esomeprazole—Barrett's esophagus	0.000769	0.00159	CcSEcCtD
Tacrolimus—Nervousness—Omeprazole—Barrett's esophagus	0.000769	0.00159	CcSEcCtD
Tacrolimus—Back pain—Esomeprazole—Barrett's esophagus	0.000766	0.00159	CcSEcCtD
Tacrolimus—Back pain—Omeprazole—Barrett's esophagus	0.000766	0.00159	CcSEcCtD
Tacrolimus—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000766	0.0152	CbGpPWpGaD
Tacrolimus—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000761	0.00158	CcSEcCtD
Tacrolimus—Muscle spasms—Omeprazole—Barrett's esophagus	0.000761	0.00158	CcSEcCtD
Tacrolimus—PPP3CA—BCR signaling pathway—RELA—Barrett's esophagus	0.000761	0.0151	CbGpPWpGaD
Tacrolimus—Vision blurred—Esomeprazole—Barrett's esophagus	0.000746	0.00155	CcSEcCtD
Tacrolimus—Vision blurred—Omeprazole—Barrett's esophagus	0.000746	0.00155	CcSEcCtD
Tacrolimus—Tremor—Esomeprazole—Barrett's esophagus	0.000742	0.00154	CcSEcCtD
Tacrolimus—Tremor—Omeprazole—Barrett's esophagus	0.000742	0.00154	CcSEcCtD
Tacrolimus—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000735	0.00152	CcSEcCtD
Tacrolimus—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000735	0.00152	CcSEcCtD
Tacrolimus—Anaemia—Omeprazole—Barrett's esophagus	0.000732	0.00152	CcSEcCtD
Tacrolimus—Anaemia—Esomeprazole—Barrett's esophagus	0.000732	0.00152	CcSEcCtD
Tacrolimus—Agitation—Omeprazole—Barrett's esophagus	0.000728	0.00151	CcSEcCtD
Tacrolimus—Agitation—Esomeprazole—Barrett's esophagus	0.000728	0.00151	CcSEcCtD
Tacrolimus—Malaise—Esomeprazole—Barrett's esophagus	0.000714	0.00148	CcSEcCtD
Tacrolimus—Malaise—Omeprazole—Barrett's esophagus	0.000714	0.00148	CcSEcCtD
Tacrolimus—Vertigo—Omeprazole—Barrett's esophagus	0.000712	0.00147	CcSEcCtD
Tacrolimus—Vertigo—Esomeprazole—Barrett's esophagus	0.000712	0.00147	CcSEcCtD
Tacrolimus—Leukopenia—Omeprazole—Barrett's esophagus	0.000709	0.00147	CcSEcCtD
Tacrolimus—Leukopenia—Esomeprazole—Barrett's esophagus	0.000709	0.00147	CcSEcCtD
Tacrolimus—Palpitations—Esomeprazole—Barrett's esophagus	0.0007	0.00145	CcSEcCtD
Tacrolimus—Palpitations—Omeprazole—Barrett's esophagus	0.0007	0.00145	CcSEcCtD
Tacrolimus—PPP3CA—Amyotrophic lateral sclerosis (ALS)—TP53—Barrett's esophagus	0.000693	0.0137	CbGpPWpGaD
Tacrolimus—Cough—Esomeprazole—Barrett's esophagus	0.000691	0.00143	CcSEcCtD
Tacrolimus—Cough—Omeprazole—Barrett's esophagus	0.000691	0.00143	CcSEcCtD
Tacrolimus—Hypertension—Omeprazole—Barrett's esophagus	0.000684	0.00142	CcSEcCtD
Tacrolimus—Hypertension—Esomeprazole—Barrett's esophagus	0.000684	0.00142	CcSEcCtD
Tacrolimus—Chest pain—Omeprazole—Barrett's esophagus	0.000674	0.0014	CcSEcCtD
Tacrolimus—Arthralgia—Omeprazole—Barrett's esophagus	0.000674	0.0014	CcSEcCtD
Tacrolimus—Chest pain—Esomeprazole—Barrett's esophagus	0.000674	0.0014	CcSEcCtD
Tacrolimus—Myalgia—Omeprazole—Barrett's esophagus	0.000674	0.0014	CcSEcCtD
Tacrolimus—Arthralgia—Esomeprazole—Barrett's esophagus	0.000674	0.0014	CcSEcCtD
Tacrolimus—Myalgia—Esomeprazole—Barrett's esophagus	0.000674	0.0014	CcSEcCtD
Tacrolimus—Anxiety—Omeprazole—Barrett's esophagus	0.000672	0.00139	CcSEcCtD
Tacrolimus—Anxiety—Esomeprazole—Barrett's esophagus	0.000672	0.00139	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00067	0.00139	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00067	0.00139	CcSEcCtD
Tacrolimus—Discomfort—Esomeprazole—Barrett's esophagus	0.000666	0.00138	CcSEcCtD
Tacrolimus—Discomfort—Omeprazole—Barrett's esophagus	0.000666	0.00138	CcSEcCtD
Tacrolimus—PPP3CA—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.00066	0.0131	CbGpPWpGaD
Tacrolimus—Dry mouth—Esomeprazole—Barrett's esophagus	0.000659	0.00137	CcSEcCtD
Tacrolimus—Dry mouth—Omeprazole—Barrett's esophagus	0.000659	0.00137	CcSEcCtD
Tacrolimus—Confusional state—Omeprazole—Barrett's esophagus	0.000652	0.00135	CcSEcCtD
Tacrolimus—Confusional state—Esomeprazole—Barrett's esophagus	0.000652	0.00135	CcSEcCtD
Tacrolimus—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000646	0.00134	CcSEcCtD
Tacrolimus—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000646	0.00134	CcSEcCtD
Tacrolimus—Infection—Esomeprazole—Barrett's esophagus	0.000642	0.00133	CcSEcCtD
Tacrolimus—Infection—Omeprazole—Barrett's esophagus	0.000642	0.00133	CcSEcCtD
Tacrolimus—Shock—Esomeprazole—Barrett's esophagus	0.000636	0.00132	CcSEcCtD
Tacrolimus—Shock—Omeprazole—Barrett's esophagus	0.000636	0.00132	CcSEcCtD
Tacrolimus—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000634	0.00131	CcSEcCtD
Tacrolimus—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000634	0.00131	CcSEcCtD
Tacrolimus—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000633	0.00131	CcSEcCtD
Tacrolimus—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000633	0.00131	CcSEcCtD
Tacrolimus—Tachycardia—Esomeprazole—Barrett's esophagus	0.000631	0.00131	CcSEcCtD
Tacrolimus—Tachycardia—Omeprazole—Barrett's esophagus	0.000631	0.00131	CcSEcCtD
Tacrolimus—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000629	0.0125	CbGpPWpGaD
Tacrolimus—Skin disorder—Omeprazole—Barrett's esophagus	0.000628	0.0013	CcSEcCtD
Tacrolimus—Skin disorder—Esomeprazole—Barrett's esophagus	0.000628	0.0013	CcSEcCtD
Tacrolimus—MTOR—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000627	0.0124	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000625	0.00129	CcSEcCtD
Tacrolimus—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000625	0.00129	CcSEcCtD
Tacrolimus—PPP3CA—C-MYB transcription factor network—PTGS2—Barrett's esophagus	0.000617	0.0122	CbGpPWpGaD
Tacrolimus—Anorexia—Esomeprazole—Barrett's esophagus	0.000616	0.00128	CcSEcCtD
Tacrolimus—Anorexia—Omeprazole—Barrett's esophagus	0.000616	0.00128	CcSEcCtD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000593	0.0118	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000589	0.00122	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000589	0.00122	CcSEcCtD
Tacrolimus—Insomnia—Esomeprazole—Barrett's esophagus	0.000585	0.00121	CcSEcCtD
Tacrolimus—Insomnia—Omeprazole—Barrett's esophagus	0.000585	0.00121	CcSEcCtD
Tacrolimus—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00058	0.0012	CcSEcCtD
Tacrolimus—Paraesthesia—Omeprazole—Barrett's esophagus	0.00058	0.0012	CcSEcCtD
Tacrolimus—Dyspnoea—Omeprazole—Barrett's esophagus	0.000576	0.00119	CcSEcCtD
Tacrolimus—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000576	0.00119	CcSEcCtD
Tacrolimus—Somnolence—Omeprazole—Barrett's esophagus	0.000575	0.00119	CcSEcCtD
Tacrolimus—Somnolence—Esomeprazole—Barrett's esophagus	0.000575	0.00119	CcSEcCtD
Tacrolimus—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000569	0.00118	CcSEcCtD
Tacrolimus—Dyspepsia—Omeprazole—Barrett's esophagus	0.000569	0.00118	CcSEcCtD
Tacrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000568	0.0113	CbGpPWpGaD
Tacrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000568	0.0113	CbGpPWpGaD
Tacrolimus—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000562	0.00116	CcSEcCtD
Tacrolimus—Decreased appetite—Omeprazole—Barrett's esophagus	0.000562	0.00116	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000558	0.00116	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000558	0.00116	CcSEcCtD
Tacrolimus—Fatigue—Esomeprazole—Barrett's esophagus	0.000557	0.00115	CcSEcCtD
Tacrolimus—Fatigue—Omeprazole—Barrett's esophagus	0.000557	0.00115	CcSEcCtD
Tacrolimus—Constipation—Omeprazole—Barrett's esophagus	0.000553	0.00114	CcSEcCtD
Tacrolimus—Pain—Omeprazole—Barrett's esophagus	0.000553	0.00114	CcSEcCtD
Tacrolimus—Pain—Esomeprazole—Barrett's esophagus	0.000553	0.00114	CcSEcCtD
Tacrolimus—Constipation—Esomeprazole—Barrett's esophagus	0.000553	0.00114	CcSEcCtD
Tacrolimus—MTOR—IL2 signaling events mediated by PI3K—RELA—Barrett's esophagus	0.000533	0.0106	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000533	0.0011	CcSEcCtD
Tacrolimus—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000533	0.0011	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000529	0.00109	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000529	0.00109	CcSEcCtD
Tacrolimus—MTOR—Wnt Signaling Pathway Netpath—APC—Barrett's esophagus	0.00052	0.0103	CbGpPWpGaD
Tacrolimus—Urticaria—Esomeprazole—Barrett's esophagus	0.000514	0.00106	CcSEcCtD
Tacrolimus—Urticaria—Omeprazole—Barrett's esophagus	0.000514	0.00106	CcSEcCtD
Tacrolimus—Body temperature increased—Omeprazole—Barrett's esophagus	0.000511	0.00106	CcSEcCtD
Tacrolimus—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000511	0.00106	CcSEcCtD
Tacrolimus—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000511	0.00106	CcSEcCtD
Tacrolimus—Abdominal pain—Omeprazole—Barrett's esophagus	0.000511	0.00106	CcSEcCtD
Tacrolimus—MTOR—Wnt Signaling Pathway Netpath—PPARG—Barrett's esophagus	0.000502	0.00996	CbGpPWpGaD
Tacrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000496	0.00984	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000476	0.000986	CcSEcCtD
Tacrolimus—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000476	0.000986	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.00047	0.00932	CbGpPWpGaD
Tacrolimus—Asthenia—Omeprazole—Barrett's esophagus	0.000464	0.00096	CcSEcCtD
Tacrolimus—Asthenia—Esomeprazole—Barrett's esophagus	0.000464	0.00096	CcSEcCtD
Tacrolimus—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000462	0.00917	CbGpPWpGaD
Tacrolimus—Pruritus—Esomeprazole—Barrett's esophagus	0.000457	0.000947	CcSEcCtD
Tacrolimus—Pruritus—Omeprazole—Barrett's esophagus	0.000457	0.000947	CcSEcCtD
Tacrolimus—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000456	0.00904	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000456	0.00904	CbGpPWpGaD
Tacrolimus—Diarrhoea—Omeprazole—Barrett's esophagus	0.000442	0.000916	CcSEcCtD
Tacrolimus—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000442	0.000916	CcSEcCtD
Tacrolimus—MTOR—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000441	0.00874	CbGpPWpGaD
Tacrolimus—Dizziness—Esomeprazole—Barrett's esophagus	0.000427	0.000885	CcSEcCtD
Tacrolimus—Dizziness—Omeprazole—Barrett's esophagus	0.000427	0.000885	CcSEcCtD
Tacrolimus—MTOR—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000415	0.00824	CbGpPWpGaD
Tacrolimus—Vomiting—Omeprazole—Barrett's esophagus	0.000411	0.000851	CcSEcCtD
Tacrolimus—Vomiting—Esomeprazole—Barrett's esophagus	0.000411	0.000851	CcSEcCtD
Tacrolimus—MTOR—CDC42 signaling events—APC—Barrett's esophagus	0.00041	0.00813	CbGpPWpGaD
Tacrolimus—Rash—Esomeprazole—Barrett's esophagus	0.000408	0.000844	CcSEcCtD
Tacrolimus—Rash—Omeprazole—Barrett's esophagus	0.000408	0.000844	CcSEcCtD
Tacrolimus—Dermatitis—Esomeprazole—Barrett's esophagus	0.000407	0.000843	CcSEcCtD
Tacrolimus—Dermatitis—Omeprazole—Barrett's esophagus	0.000407	0.000843	CcSEcCtD
Tacrolimus—Headache—Omeprazole—Barrett's esophagus	0.000405	0.000838	CcSEcCtD
Tacrolimus—Headache—Esomeprazole—Barrett's esophagus	0.000405	0.000838	CcSEcCtD
Tacrolimus—MTOR—SREBP signalling—PPARG—Barrett's esophagus	0.0004	0.00794	CbGpPWpGaD
Tacrolimus—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000394	0.00782	CbGpPWpGaD
Tacrolimus—MTOR—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000388	0.00771	CbGpPWpGaD
Tacrolimus—PPP3CA—Alzheimers Disease—TP53—Barrett's esophagus	0.000386	0.00765	CbGpPWpGaD
Tacrolimus—Nausea—Omeprazole—Barrett's esophagus	0.000384	0.000795	CcSEcCtD
Tacrolimus—Nausea—Esomeprazole—Barrett's esophagus	0.000384	0.000795	CcSEcCtD
Tacrolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000368	0.00731	CbGpPWpGaD
Tacrolimus—PPP3CA—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.000367	0.00728	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000364	0.00723	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—RELA—Barrett's esophagus	0.000362	0.00719	CbGpPWpGaD
Tacrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000361	0.00716	CbGpPWpGaD
Tacrolimus—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000356	0.00706	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000353	0.00701	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.00035	0.00694	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000341	0.00676	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.00034	0.00674	CbGpPWpGaD
Tacrolimus—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000334	0.00663	CbGpPWpGaD
Tacrolimus—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00033	0.00654	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000327	0.00648	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—GAST—Barrett's esophagus	0.000306	0.00606	CbGpPWpGaD
Tacrolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000304	0.00602	CbGpPWpGaD
Tacrolimus—MTOR—Leptin signaling pathway—RELA—Barrett's esophagus	0.000303	0.00601	CbGpPWpGaD
Tacrolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000292	0.0058	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by Wnt—APC—Barrett's esophagus	0.000281	0.00557	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—TP53—Barrett's esophagus	0.00028	0.00555	CbGpPWpGaD
Tacrolimus—MTOR—LKB1 signaling events—TP53—Barrett's esophagus	0.000274	0.00543	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000248	0.00492	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000244	0.00484	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000241	0.00477	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000232	0.00461	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—APC—Barrett's esophagus	0.00023	0.00457	CbGpPWpGaD
Tacrolimus—MTOR—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000228	0.00452	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000218	0.00433	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—TP53—Barrett's esophagus	0.000217	0.0043	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TP53—Barrett's esophagus	0.000211	0.00418	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—SST—Barrett's esophagus	0.00021	0.00416	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000203	0.00402	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—SLC9A1—Barrett's esophagus	0.000198	0.00392	CbGpPWpGaD
Tacrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000197	0.0039	CbGpPWpGaD
Tacrolimus—MTOR—AMPK Signaling—TP53—Barrett's esophagus	0.000187	0.00372	CbGpPWpGaD
Tacrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000187	0.00371	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—GAST—Barrett's esophagus	0.000181	0.00358	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—RELA—Barrett's esophagus	0.00018	0.00357	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000165	0.00327	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.00016	0.00317	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000155	0.00308	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—SLC9A1—Barrett's esophagus	0.000153	0.00304	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000153	0.00304	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000153	0.00303	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000149	0.00296	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000148	0.00293	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000146	0.00289	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—RELA—Barrett's esophagus	0.000141	0.0028	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—GAST—Barrett's esophagus	0.00014	0.00278	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HGF—Barrett's esophagus	0.000136	0.00271	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—RELA—Barrett's esophagus	0.000136	0.0027	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	0.000134	0.00266	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000131	0.0026	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000127	0.00253	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SST—Barrett's esophagus	0.000124	0.00246	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000124	0.00245	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000118	0.00234	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CDKN2A—Barrett's esophagus	0.000115	0.00228	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—RELA—Barrett's esophagus	0.000111	0.0022	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000108	0.00215	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000108	0.00215	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CXCL8—Barrett's esophagus	0.000104	0.00207	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGES—Barrett's esophagus	0.000104	0.00207	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—RELA—Barrett's esophagus	0.000104	0.00206	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.0001	0.00199	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SST—Barrett's esophagus	9.6e-05	0.0019	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—Barrett's esophagus	9.54e-05	0.00189	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—APC—Barrett's esophagus	9.35e-05	0.00186	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SLC9A1—Barrett's esophagus	8.62e-05	0.00171	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—CXCL8—Barrett's esophagus	8.16e-05	0.00162	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—RELA—Barrett's esophagus	7.91e-05	0.00157	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	7.91e-05	0.00157	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	7.91e-05	0.00157	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GAST—Barrett's esophagus	7.88e-05	0.00156	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.57e-05	0.0015	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGES—Barrett's esophagus	7.54e-05	0.0015	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—APC—Barrett's esophagus	7.25e-05	0.00144	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTGS2—Barrett's esophagus	7.1e-05	0.00141	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.64e-05	0.00132	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—APC—Barrett's esophagus	6.55e-05	0.0013	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGES—Barrett's esophagus	6.49e-05	0.00129	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—Barrett's esophagus	6.41e-05	0.00127	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	6e-05	0.00119	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HGF—Barrett's esophagus	5.95e-05	0.00118	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—RELA—Barrett's esophagus	5.93e-05	0.00118	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	5.71e-05	0.00113	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	5.7e-05	0.00113	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGES—Barrett's esophagus	5.69e-05	0.00113	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—RELA—Barrett's esophagus	5.69e-05	0.00113	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HGF—Barrett's esophagus	5.57e-05	0.00111	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTGS2—Barrett's esophagus	5.51e-05	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SST—Barrett's esophagus	5.4e-05	0.00107	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RELA—Barrett's esophagus	5.12e-05	0.00102	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APC—Barrett's esophagus	5.08e-05	0.00101	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP26A1—Barrett's esophagus	4.92e-05	0.000976	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL8—Barrett's esophagus	4.82e-05	0.000957	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	4.31e-05	0.000855	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	4.12e-05	0.000817	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APC—Barrett's esophagus	4.08e-05	0.000809	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RELA—Barrett's esophagus	3.97e-05	0.000787	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL8—Barrett's esophagus	3.74e-05	0.000742	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.64e-05	0.000721	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.57e-05	0.000709	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC9A1—Barrett's esophagus	3.55e-05	0.000704	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.51e-05	0.000695	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—RELA—Barrett's esophagus	3.45e-05	0.000685	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	3.11e-05	0.000617	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—Barrett's esophagus	3.1e-05	0.000614	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—Barrett's esophagus	2.96e-05	0.000587	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.86e-05	0.000567	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APC—Barrett's esophagus	2.86e-05	0.000566	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.66e-05	0.000527	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARG—Barrett's esophagus	2.6e-05	0.000516	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—Barrett's esophagus	2.29e-05	0.000455	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RELA—Barrett's esophagus	2.23e-05	0.000443	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—Barrett's esophagus	2.1e-05	0.000417	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	2.05e-05	0.000406	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.92e-05	0.00038	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.88e-05	0.000373	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—Barrett's esophagus	1.87e-05	0.000371	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARG—Barrett's esophagus	1.62e-05	0.000321	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	1.48e-05	0.000293	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.42e-05	0.000281	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—Barrett's esophagus	1.29e-05	0.000256	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—Barrett's esophagus	1.27e-05	0.000253	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.12e-05	0.000221	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARG—Barrett's esophagus	8.74e-06	0.000173	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	6.88e-06	0.000136	CbGpPWpGaD
